Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Price Activity

AFter 186,270 shares SOLD, ARCA has left the Level II board. Now you tell me if it was a good thing ARCA was there?

Share
New Message
Please login to post a reply